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This issue of ABO brings interesting articles in epidemiology, basic research, new technologies and rando-
mized clinical trials.
Kara-Júnior and his colleagues(1) presented the results of a questionnaire administered to more than 600
patients treated in a campaign to perform cataract surgery in São Paulo. The study showed a sad reality for
patients excluded from the comprehensive eye care. Almost half of all patients interviewed were unable to
gain access to cataract surgery before the campaign, because they have abandoned the free public service as
a result of the long waiting lists or for failing to schedule their surgeries (19%), or did not have the resources to
afford the costs associated with surgeries performed by health insurance or private care (29%). The costs
reported by patients who had not sought public service ranged from R$ 1,000 to over R$ 4,000.00. Authors
rightly emphasized in their conclusions “the need to continue to carry out community campaigns to meet
people who would not have access to surgery by conventional means.” I also believe it is important to consider
that, despite the campaigns being indispensable at the present time the Brazilian public health, we must
keep in mind that, ideally, access to health care should be possible for the whole population without the
need to create specific campaigns.
Patients with anophthalmic cavities were evaluated in two articles(2,3). Narikawa and colleagues(2) retros-
pectively analyzed the epidemiological profile of 107 patients with anophthalmic cavity in a reference service
in the state of São Paulo, detecting trauma as the most frequent etiology, especially in men. In another study
conducted in the Federal District, Goulart and colleagues(3) assessed the psychosocial aspects involved in the
rehabilitation of patients with anophthalmic cavity. In their study, which evaluated 44.4% of patients with
anophthalmic cavity since 2004, the trauma was also nominated as the most frequent cause. In this sample,
one third of patients said that the eye loss negatively influenced their daily routine.
Several epidemiological, clinical and basic research articles focused on retinal aspects. In another
epidemiological study, evaluating patients with sickle cell disease, Freitas and colleagues(4) demons-
trated that routine eye examination may, in specific cases, establish clinical suspicion of systemic diseases.
Gil and colleagues(5) conducted a randomized double-blind clinical trial to compare, through morpholo-
gical and functional assessment, the treatment of diffuse diabetic macular edema with intravitreal triamci-
nolone and with laser phototherapy. Twenty-one eyes of 14 patients were randomly assigned to each
group. Although intravitreal injection have led to the decrease in retinal thickness measured by OCT, the
study showed no functional differences between the initial examination after three months of treatment
in either group. In a study of basic research, evaluating a promising anti-inflammatory drug for intravitreal use,
Rassi et al.(6) demonstrated that infliximab can be used repeatedly for two or three times, with minimal
retinal toxicity in rabbits. In another study comparing the action of the ranibizumab and bevacizumab
“in vitro”, Souto et al.(7) showed greater effect than the first in cultured endothelial cells from human umbilical
cord vein.
Bottós and colleagues(8) addressed, through novel basic research, a very important subject related to the
promotion of corneal collagen crosslinking (CXL): the influence of the corneal epithelium in maintaining the
effectiveness of CXL. In this novel approach the authors found that the maintenance of epithelium does not
interfere in the transmission of ultraviolet light to the corneal stroma, but interferes with the absorption of
riboflavin for the same. This study opens up space for future research in the transepithelial use of drugs that
promote crosslinking and are able to cross the epithelial barrier.
Two studies used ocular ultrasound associated to Doppler technology to assess blood flow in the oph-
thalmic artery(9) as well as in central retinal artery and short posterior ciliary arteries(10). Almeida-Freitas et al.(9)
evaluated the flow of the ophthalmic artery in 18 patients with chronic heart failure and 21 controls,
demonstrating differences between groups in diastolic velocity and arterial resistance index. Ramos and
colleagues(10) used the same technology to study the central retinal artery and short posterior ciliary arteries in
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36 patients with glaucoma and 20 controls. In this study, Doppler data were associated with visual perimetry
results showing that, together, these data have 90% sensitivity in glaucoma diagnosis.
Torricelli and colleagues(11) wrote an interesting review article on a problem that increasingly affects the
world’s urban population: environmental pollution. The manuscript addresses the pertinent literature and
concludes that, although there are many studies on the effects of pollution on the respiratory system, the
literature is scarce in relation to ocular alterations related to environmental pollution.
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